These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 39237515)

  • 1. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function.
    Andrade AF; Annett A; Karimi E; Topouza DG; Rezanejad M; Liu Y; McNicholas M; Gonzalez Santiago EG; Llivichuzhca-Loja D; Gehlhaar A; Jessa S; De Cola A; Chandarana B; Russo C; Faury D; Danieau G; Puligandla E; Wei Y; Zeinieh M; Wu Q; Hebert S; Juretic N; Nakada EM; Krug B; Larouche V; Weil AG; Dudley RWR; Karamchandani J; Agnihotri S; Quail DF; Ellezam B; Konnikova L; Walsh LA; Pathania M; Kleinman CL; Jabado N
    Nat Commun; 2024 Sep; 15(1):7769. PubMed ID: 39237515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
    Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N
    Cell; 2020 Dec; 183(6):1617-1633.e22. PubMed ID: 33259802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer.
    Pajovic S; Siddaway R; Bridge T; Sheth J; Rakopoulos P; Kim B; Ryall S; Agnihotri S; Phillips L; Yu M; Li C; Milos S; Patel P; Srikanthan D; Huang A; Hawkins C
    Nat Commun; 2020 Dec; 11(1):6216. PubMed ID: 33277484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.
    Sangatsuda Y; Miura F; Araki H; Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Arai Y; Yoshida A; Shibata T; Yoshimoto K; Iihara K; Ito T
    Sci Rep; 2020 Sep; 10(1):16162. PubMed ID: 32999376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The H3.3K27M oncohistone affects replication stress outcome and provokes genomic instability in pediatric glioma.
    Bočkaj I; Martini TEI; de Camargo Magalhães ES; Bakker PL; Meeuwsen-de Boer TGJ; Armandari I; Meuleman SL; Mondria MT; Stok C; Kok YP; Bakker B; Wardenaar R; Seiler J; Broekhuis MJC; van den Bos H; Spierings DCJ; Ringnalda FCA; Clevers H; Schüller U; van Vugt MATM; Foijer F; Bruggeman SWM
    PLoS Genet; 2021 Nov; 17(11):e1009868. PubMed ID: 34752469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
    Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
    J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone H3.3K27M Represses
    Cordero FJ; Huang Z; Grenier C; He X; Hu G; McLendon RE; Murphy SK; Hashizume R; Becher OJ
    Mol Cancer Res; 2017 Sep; 15(9):1243-1254. PubMed ID: 28522693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas.
    de Camargo Magalhães ES; de Bont ESJM; Bruggeman SWM; Lima FRS
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167248. PubMed ID: 38777100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
    Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA
    Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    Morris M; Driscoll M; Henson JW; Cobbs C; Jiang L; Gocke CD; Chen L; Rodriguez FJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1038-1043. PubMed ID: 32954438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.
    Chan KM; Fang D; Gan H; Hashizume R; Yu C; Schroeder M; Gupta N; Mueller S; James CD; Jenkins R; Sarkaria J; Zhang Z
    Genes Dev; 2013 May; 27(9):985-90. PubMed ID: 23603901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling.
    Chen KY; Bush K; Klein RH; Cervantes V; Lewis N; Naqvi A; Carcaboso AM; Lechpammer M; Knoepfler PS
    Commun Biol; 2020 Jul; 3(1):363. PubMed ID: 32647372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells.
    Leszczynska KB; Freitas-Huhtamäki A; Jayaprakash C; Dzwigonska M; Vitorino FNL; Horth C; Wojnicki K; Gielniewski B; Szadkowska P; Kaza B; Nazarian J; Ciolkowski MK; Trubicka J; Grajkowska W; Garcia BA; Majewski J; Kaminska B; Mieczkowski J
    Cell Rep; 2024 Feb; 43(2):113707. PubMed ID: 38306270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3.3 G34-mutant Diffuse Gliomas in Adults.
    Wang L; Shao L; Li H; Yao K; Duan Z; Zhi C; Song S; Cheng Y; Wang F; Wang W; Piao Y; Gui Q; Lu D; Qi X; Teng L
    Am J Surg Pathol; 2022 Feb; 46(2):249-257. PubMed ID: 34352809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
    Zhang Q; Yang L; Liu YH; Wilkinson JE; Krainer AR
    Sci Transl Med; 2023 Apr; 15(691):eadd8280. PubMed ID: 37043556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.
    Grewal EP; Richardson LGK; Sun J; Ramapriyan R; Martinez-Lage M; Miller JJ; Carter BS; Cahill DP; Curry WT; Choi BD
    Clin Cancer Res; 2024 Sep; 30(18):4068-4076. PubMed ID: 39042445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
    Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian Regulation Patterns With Distinct Immune Landscapes in Gliomas Aid in the Development of a Risk Model to Predict Prognosis and Therapeutic Response.
    Tian R; Li Y; Shu M
    Front Immunol; 2021; 12():797450. PubMed ID: 35069579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.
    Huchede P; Meyer S; Berthelot C; Hamadou M; Bertrand-Chapel A; Rakotomalala A; Manceau L; Tomine J; Lespinasse N; Lewandowski P; Cordier-Bussat M; Broutier L; Dutour A; Rochet I; Blay JY; Degletagne C; Attignon V; Montero-Carcaboso A; Le Grand M; Pasquier E; Vasiljevic A; Gilardi-Hebenstreit P; Meignan S; Leblond P; Ribes V; Cosset E; Castets M
    Elife; 2024 Oct; 12():. PubMed ID: 39373720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.